HIGHLIGHTS
- who: Ines Jimenez-Lozano from the Johns Hopkins Medicine, United States Department of Pharmacy, Vall d`Hebron University Hospital, Barcelona, Spain, Department of have published the article: Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease, in the Journal: (JOURNAL) of December/20,/2019
- what: The aim of this study was to describe the experience and evaluate the safety and hematologic response of FCM treatment in pediatric patients with kidney disease. iron and mobilization of iron deposits from the reticuloendothelial system (RES) to circulating transferrin . The authors did not . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.